Consider TLR5 for new therapeutic development against COVID-19
- PMID: 32391920
- PMCID: PMC7272826
- DOI: 10.1002/jmv.25997
Consider TLR5 for new therapeutic development against COVID-19
Keywords: COVID-19; TLR5; therapeutic development.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Comment on
-
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.J Med Virol. 2020 Jun;92(6):618-631. doi: 10.1002/jmv.25736. Epub 2020 Mar 5. J Med Virol. 2020. PMID: 32108359 Free PMC article.
References
-
- Cao Y, Zhang E, Yang J, et al. Frontline science: nasal epithelial GM‐CSF contributes to TLR5‐mediated modulation of airway dendritic cells and subsequent IgA response. J Leukoc Biol. 2017;102(3):575‐587. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical